Lauranne Aap Derikx

7PUBLICATIONS
52CO-AUTHORS
Respiratory diseasesInnate immunitySolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 04, 2026
Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry.

Loriane M M Verleye, Marieke J Pierik, Annemarie C de Vries

|Jul 18, 2023
SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Natasja van de Pol, Qiuwei Pan, Lauranne A A P Derikx

|Jun 10, 2023
Endoscopic and surgical treatment outcomes of colitis-associated advanced colorectal neoplasia: a multicenter cohort study.

Monica Ew Derks, Maarten Te Groen, Charlotte P Peters

|Feb 21, 2023
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort.

Beatriz Gros, Nikolas Plevris, Nathan Constantine-Cooke

|Mar 18, 2022
Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis.

Mathew Lyons, Lauranne A A P Derikx, James Fulforth

|Sep 02, 2021
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.

Neil Chanchlani, Simeng Lin, Desmond Chee

Pageof 2

Frequent Collaborators

3 joint publications

Nikolas Plevris

3 joint publications

Charlie W Lees

3 joint publications

Annemarie C de Vries

2 joint publications

Laura Lucaciu